Cargando…

Impact of insight quality on treatment adherence in schizophrenia

INTRODUCTION: Schizophrenia is a chronic, frequent, and disabling psychiatric condition. The prognosis is more severe in the absence of treatment. OBJECTIVES: The aims of our study were to evaluate the quality of treatment adherence and the quality of insight of patients with schizophrenia and to as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rami, A., Sana, E., Mejda, C., Rahma, D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10595915/ http://dx.doi.org/10.1192/j.eurpsy.2023.579

Ejemplares similares

The role of the affective temperament in the treatment adherence in psychiatry
por: Bahrini, Lilia, et al.
Publicado: (2016)

Cognitive behavioral therapy for a woman with depression and systemic lupus erythematosus
por: Znaidi, F., et al.
Publicado: (2023)

Internalized stigma Insight and treatment adherence among patients of schizophrenia and alcohol dependence syndrome
por: Kumar, Gyanendra, et al.
Publicado: (2022)

Predictors of poor adherence in schizophrenia
por: Bouali, W., et al.
Publicado: (2021)

Comparative study of treatment adherence, treatment-related attitudes, and background factors in schizophrenia spectrum and bipolar patients
por: Janicsák, H., et al.
Publicado: (2022)

Mothers with schizophrenia: Treatment, quality of life and motherhood experience
por: Sánchez, S. Pérez, et al.
Publicado: (2021)

Mothers and fathers with schizophrenia: Treatment and quality of life
por: Perez-Sanchez, S., et al.
Publicado: (2023)

PM518. Medication Adherence in schizophrenia: Focus on therapeutic relationship
por: Chang, Jhin-Goo, et al.
Publicado: (2016)

Quality of life of patients with schizophrenia
por: Guermazi, A., et al.
Publicado: (2022)

cognitive complaints in schizophrenia: characteristics and relationship with insight
por: Bouhamed, M., et al.
Publicado: (2022)

S248. RELATION BETWEEN CHILDHOOD TRAUMA AND PSYCHOTIC SYMPTOMS IN SCHIZOPHRENIA
por: Larnaout, Amine, et al.
Publicado: (2018)

The use of a Subjective wellbeing scale as predictor of adherence to neuroleptic treatment to determine poor prognostic factor in African population with Schizophrenia
por: Boshe, J. J., et al.
Publicado: (2023)

Insight, symptom severity and medication adherence in bipolar disorder
por: Abdelhamid, A., et al.
Publicado: (2023)

T169. COGNITIVE INSIGHT AND CORTICAL THICKNESS IN SCHIZOPHRENIA
por: Jacob, Arpitha, et al.
Publicado: (2018)

Quality of life in patients with schizophrenia
por: Hentati, S., et al.
Publicado: (2021)

T124. CLINICAL DIFFERENCES BETWEEN URBAN AND RURAL SCHIZOPHRENIA
por: Larnaout, Amine, et al.
Publicado: (2018)

F98. HYPOVITAMINOSIS D IN SCHIZOPHRENIA: ASSOCIATED CARDIOVASCULAR RISK
por: Nefzi, Rahma, et al.
Publicado: (2018)

S120. FACTORS ASSOCIATED WITH SUICIDE ATTEMPTS AMONG PATIENTS WITH SCHIZOPHRENIA
por: Nefzi, Rahma, et al.
Publicado: (2018)

S200. HYPOVITAMINOSIS D IN SCHIZOPHRENIA: PREVALENCE AND ASSOCIATED CLINICAL CHARACTERISTICS
por: Nefzi, Rahma, et al.
Publicado: (2018)

Vigo Insight Monitoring Scale in Schizophrenia (VIMS): validation in a sample of patients with schizophrenia
por: Vazquez Noguerol Mendez, R.
Publicado: (2022)

Treatment adherence of a case managed program for patients with severe schizophrenia compared to standard care in mental health units.
por: Díaz-Fernández, S., et al.
Publicado: (2023)

The impact of lifestyle on adherence to treatment in a sample of patients with Major Depression
por: Conti, D., et al.
Publicado: (2023)

PM393. Antipsychotic polypharmacy patterns and antipsychotic psychiatric medication adherence in patients with schizophrenia
por: Joe, Soohyun, et al.
Publicado: (2016)

T94. HS-CRP TO EVALUATE CHRONIC INFLAMMATION AND CARDIOVASCULAR DISEASES IN SCHIZOPHRENIA
por: Nefzi, Rahma, et al.
Publicado: (2018)

Satisfaction of the quality of life in patients with schizophrenia
por: Ouali, R., et al.
Publicado: (2021)

Depression and quality of life in schizophrenia-spectrum
por: Smaoui, N., et al.
Publicado: (2021)

Prediction of quality of life in schizophrenia using machine learning models on data from clinical antipsychotic trials of intervention effectiveness (CATIE) schizophrenia trial
por: Beaudoin, M., et al.
Publicado: (2021)

PM529. Three clinical distinct groups according to medication adherence in rehospitalized patients with schizophrenia
por: Nam, Yulim, et al.
Publicado: (2016)

F116. CAN INSIGHT LEAD TO REMISSION - FOR PATIENTS WITH SCHIZOPHRENIA?
por: Olsson-Tall, Maivor, et al.
Publicado: (2018)

Treatment of Cognitive Impairment in Schizophrenia
por: Vita, A.
Publicado: (2022)

Sleep quality in first-episode schizophrenia patients
por: Abdellatif, M., et al.
Publicado: (2023)

Internalized stigma, depression and quality of life in schizophrenia
por: Elleuch, S., et al.
Publicado: (2021)

Sexual dysfunction and quality of life among Tunisian patients with schizophrenia
por: Guermazi, A., et al.
Publicado: (2022)

F106. STATE AND TRAIT RELATED NATURE OF INSIGHT IMPAIRMENT IN SCHIZOPHRENIA
por: Phahladira, Lebogang, et al.
Publicado: (2018)

Comorbid Obsessive-Compulsive Symptoms in Schizophrenia - Diagnostic and Treatment Challenges
por: Leal, J. A., et al.
Publicado: (2023)

The efficacy of social skills training in the treatment of schizophrenia
por: Brando, F., et al.
Publicado: (2021)

Medication adherence in the treatment of depression
por: Pejuskovic, B., et al.
Publicado: (2023)

Treatment and Qualitative Research of Schizophrenia
por: Ammon, M.
Publicado: (2022)

Impact of early onset of chronic physical multimorbidities on schizophrenia spectrum disorder treatment outcome
por: Šimunović Filipčić, I., et al.
Publicado: (2022)

The Impact of Stakeholder Preferences on Service User Adherence to Treatments for Schizophrenia and Metabolic Comorbidities
por: Poremski, Daniel, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_nrnvikameidru6un65jrpj2k4k